Maven Investment Partners US

Number of Investments

Number of Lead Investments

5

0

Maven Investment Partners US has made 5 investments. Their most recent investment was on Sep 19, 2022, when Ventyx Biosciences raised $176.60M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 19, 2022 Ventyx Biosciences	Post-IPO Equity	$176.60M	Biopharma	—
Jan 6, 2021 Aileron Therapeutics	Post-IPO Secondary	$35.90M	Biopharma	—
Dec 15, 2020 Kineta (Reverse Merger With Yumanity Therapeutics)	Series Unknown	$33.59M	Biotechnology	—
Nov 25, 2020 MedAvail	Series E	$96.99M	Biotechnology	—
Jul 17, 2020 Frequency Therapeutics	Post-IPO Equity	$42.30M	Biotechnology	—

Maven Investment Partners US has had 5 exits. Maven Investment Partners US most notable exits include Ventyx Biosciences , Kineta (Reverse Merger With Yumanity Therapeutics)

Date	Company Name	Exit Type	Industry
Oct 21, 2021	Ventyx Biosciences	IPO	Biopharma	Detail
Dec 23, 2020	Kineta (Reverse Merger With Yumanity Therapeutics)	M&A	Biotechnology	Detail
Nov 8, 2020	MedAvail	IPO	Biotechnology	Detail
Oct 2, 2019	Frequency Therapeutics	IPO	Biotechnology	Detail
Jun 29, 2017	Aileron Therapeutics	IPO	Biopharma	Detail